Acadian Asset Management’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20K | Sell |
18,942
-65,180
| -77% | -$68.8K | ﹤0.01% | 1588 |
|
2025
Q1 | $81K | Buy |
+84,122
| New | +$81K | ﹤0.01% | 1378 |
|
2024
Q1 | – | Sell |
-11,278
| Closed | -$20K | – | 1742 |
|
2023
Q4 | $20K | Sell |
11,278
-1,955
| -15% | -$3.47K | ﹤0.01% | 1589 |
|
2023
Q3 | $26K | Buy |
+13,233
| New | +$26K | ﹤0.01% | 1506 |
|
2023
Q2 | – | Sell |
-32,506
| Closed | -$130K | – | 1873 |
|
2023
Q1 | $130K | Sell |
32,506
-39,196
| -55% | -$157K | ﹤0.01% | 1342 |
|
2022
Q4 | $95K | Buy |
71,702
+47,859
| +201% | +$63.4K | ﹤0.01% | 1450 |
|
2022
Q3 | $46K | Hold |
23,843
| – | – | ﹤0.01% | 1506 |
|
2022
Q2 | $57K | Buy |
+23,843
| New | +$57K | ﹤0.01% | 1475 |
|